OTCMKTS:VRSEF Verisante Technology (VRSEF) Stock Price, News & Analysis $0.0021 0.00 (0.00%) As of 06/18/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Verisante Technology Stock (OTCMKTS:VRSEF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Verisante Technology alerts:Sign Up Key Stats Today's Range$0.0021▼$0.002150-Day Range N/A52-Week Range$0.0002▼$0.0130VolumeN/AAverage Volume57 shsMarket Capitalization$92.27 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Verisante Technology Inc. is a Canada-based medical device company focused on the development and commercialization of non-invasive cancer detection systems. The firm’s flagship offering, the Verisante Aurora, employs Raman spectroscopy and digital imaging to analyze tissue at the point of care, aiming to differentiate malignant lesions from benign skin abnormalities. By integrating optical spectroscopy with advanced data algorithms, Verisante seeks to provide clinicians with real-time diagnostic support for early-stage melanoma, basal cell carcinoma and squamous cell carcinoma. In addition to its dermatology application, Verisante has extended its technology platform toward pulmonary oncology, exploring handheld spectroscopic devices to assist in the detection of early lung cancer during bronchoscopy procedures. The company’s research and development efforts have been supported through collaborations with academic institutions and clinical centers in North America and Europe, where Aurora prototypes have undergone pilot testing in hospital and outpatient settings. Headquartered in Vancouver, British Columbia, Verisante maintains operations and regulatory support teams in Europe to address CE-mark requirements and engage local distributors. The company’s management team combines expertise in medical optics, regulatory affairs and commercialization strategy, positioning Verisante to address the global need for rapid, minimally invasive cancer screening tools.AI Generated. May Contain Errors. Read More Receive VRSEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verisante Technology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VRSEF Stock News HeadlinesVRSEF Verisante Technology Inc.January 1, 2026 | seekingalpha.comVER.H:CA AnalysisApril 10, 2025 | seekingalpha.comA huge SpaceX error just led one stock to 3X move!SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker. That window has closed - but the next opportunity may still be open. Trader Lance Ippolito has released a free SpaceX Investing Blackbook covering pre-IPO positioning plays, the space stock Goldman Sachs, BlackRock, and Morgan Stanley are loading up on, and the chip supplier Starlink satellites depend on.June 20 at 1:00 AM | InvestPub (Ad)Closing Bell: Verisante Technology Inc down on Friday (VER-H)August 7, 2024 | theglobeandmail.comClosing Bell: Verisante Technology Inc up on Tuesday (VER-H)July 24, 2024 | theglobeandmail.comVerisante: Q4 Earnings SnapshotMarch 29, 2024 | sfgate.comVerisante Technology, Inc. Announces 2023 AGM ResultsDecember 21, 2023 | finance.yahoo.comVerisante Technology, Inc. Announces Exchange Approval for Shares for Debt TransactionOctober 5, 2023 | finance.yahoo.comSee More Headlines VRSEF Stock Analysis - Frequently Asked Questions How have VRSEF shares performed this year? Verisante Technology's stock was trading at $0.0023 at the beginning of 2026. Since then, VRSEF shares have decreased by 8.7% and is now trading at $0.0021. When did Verisante Technology's stock split? Verisante Technology's stock reverse split on Thursday, June 23rd 2022.The 1-10 reverse split was announced on Thursday, June 23rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Verisante Technology? Shares of VRSEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today6/20/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryN/A Current SymbolOTCMKTS:VRSEF CIKN/A Webwww.verisante.com Phone(604) 716-5133Fax604-605-0508EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$20 thousand Net MarginsN/A Pretax MarginN/A Return on Equity-48.15% Return on Assets1,008.44% Debt Debt-to-Equity RatioN/A Current Ratio0.33 Quick Ratio0.33 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares43,940,000Free FloatN/AMarket Cap$92.27 thousand OptionableNot Optionable Beta-1.28 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:VRSEF) was last updated on 6/20/2026 by MarketBeat.com Staff. From Our PartnersBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verisante Technology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verisante Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
